Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses

Area of Science:

• Immunology
• Allergy Research
• Immunotherapy

Background:

• Allergen-specific Immunoglobulin E (IgE) antibodies are central to hypersensitivity diseases.
• IgE-antibody complexes drive inflammation and T cell responses via IgE-facilitated antigen presentation (FAP).
• Allergen-specific Immunoglobulin G (IgG) antibodies, particularly those from immunotherapy, can modulate these responses.

Purpose of the Study:

• To review the multifaceted roles of allergen-specific antibodies in regulating immune responses.
• To elucidate the mechanisms by which IgE and IgG antibodies impact allergic inflammation and immunotherapy.
• To highlight the complex interplay between different antibody classes in secondary allergen-specific immune responses.

Main Methods:

• Review of existing experimental data and literature on IgE and IgG antibody functions in allergy.
• Analysis of the mechanisms of IgE-facilitated antigen presentation (FAP).
• Examination of the impact of immunotherapy-induced IgG on IgE-mediated responses.

Main Results:

• IgE-allergen complexes activate mast cells, basophils, and perpetuate T cell responses through FAP.
• Allergen-specific IgG antibodies can inhibit IgE-allergen complex formation and reduce effector cell activation.
• Under certain conditions, IgG binding to different epitopes may enhance IgE-mediated responses, complicating their role.

Conclusions:

• Allergen-specific antibodies play a critical, often dual, role in allergic diseases and immunotherapy.
• Understanding the balance between IgE and IgG is crucial for developing effective allergy treatments.
• Further research into antibody epitope specificity is needed to fully grasp their regulatory functions.